Crocs, Inc. vs Health Care Select Sector SPDR Fund — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.31B), while Health Care Select Sector SPDR Fund trades at $167.58. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Crocs, Inc. nearer its low. Which is the better fit depends on your goals.
| CROX | XLV | |
|---|---|---|
Market Cap | $6.31B | — |
Sector | Consumer Staples | — |
52-Week High | $141.19 | $168.44 |
52-Week Low | $73.39 | $131.16 |
Enterprise Value | $7.83B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLV trades at $165.68, up 0.75% with a bullish technical signal from moving averages. The healthcare ETF shows strong defensive positioning amid market volatility, with recent articles highlighting its cost efficiency at 0.08% expense ratio and $41.7 billion AUM. Technical indicators show support at $164 and resistance at $167, with RSI levels in neutral territory suggesting balanced momentum.
The outlook remains positive given healthcare's defensive characteristics and recent sector inflows. Key risks include regulatory pressures and competitive ETF offerings, but XLV's diversification across 60 healthcare stocks provides stability. Analyst comparisons favor XLV for lower costs and steady performance versus specialized biotech ETFs.
Trailing returns across standard periods
Latest headlines on both assets
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →